Advertisement
YOU ARE HERE: LAT HomeCollectionsShering A G
IN THE NEWS

Shering A G

FEATURED ARTICLES
BUSINESS
July 24, 1993 | DAVID R. OLMOS, TIMES STAFF WRITER
Chiron Corp. won permission Friday from the Food and Drug Administration to market the first drug ever approved for multiple sclerosis, giving the fast-growing California biotechnology company what analysts called a potential "blockbuster." The drug, Betaseron, will likely be one of the hottest products in years for the beleaguered biotechnology industry. Analysts estimated that the drug could generate U.S.
ARTICLES BY DATE
BUSINESS
July 24, 1993 | DAVID R. OLMOS, TIMES STAFF WRITER
Chiron Corp. won permission Friday from the Food and Drug Administration to market the first drug ever approved for multiple sclerosis, giving the fast-growing California biotechnology company what analysts called a potential "blockbuster." The drug, Betaseron, will likely be one of the hottest products in years for the beleaguered biotechnology industry. Analysts estimated that the drug could generate U.S.
Los Angeles Times Articles
|